A kind of adsorbent for blood perfusion and preparation method thereof

By modifying nanotitanium dioxide and enoic acid grafting reaction combined with β-glucan and phosphoric acid, a high-efficiency adsorbent was prepared, which solved the problem of difficulty in adsorption of endotoxins and inflammatory factors in the blood, and achieved effective treatment for diseases such as sepsis. treat.

CN118320801BActive Publication Date: 2024-11-05RENMIN HOSPITAL OF WUHAN UNIVERSITY (HUBEI GENERAL HOSPITAL)
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202410448728.4
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2024-04-15
Publication Date
2024-11-05
Estimated Expiration
2044-04-15

AI Technical Summary

Technical Problem

The prior art is difficult to effectively remove endotoxins and inflammatory factors in the blood, resulting in difficulty in treating systemic inflammatory diseases such as sepsis.

Method used

Through the modified nanotitanium dioxide and enoic acid grafting reaction, combining β-glucan and phosphoric acid, an adsorbent with high adsorption capacity was prepared, and the nano-effect and electrostatic binding mechanisms were used to adsorb endotoxins and inflammatory factors.

Benefits of technology

It significantly improves the adsorption ability of endotoxins and inflammatory factors in the blood and is effectively used to treat systemic inflammatory diseases such as sepsis.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118320801B_ABST
    Figure CN118320801B_ABST
Patent Text Reader

Abstract

The invention discloses an adsorbent for blood perfusion and a preparation method thereof. The invention firstly modifies nano titanium dioxide to introduce carbon-carbon double bonds on the surface of the nano titanium dioxide, then grafts olefinic acid and the nano titanium dioxide on a composite carrier through a double bond addition reaction, and greatly improves the adsorption capacity of the adsorbent on inflammatory factors through the nano effect (small size effect) of the nano titanium dioxide and the interaction between the long hydrophobic alkyl chains in the olefinic acid; then, the carboxyl group in the olefinic acid and the hydroxyl group in beta-glucan are esterified to graft the beta-glucan on the surface of the composite carrier, and the beta-glucan is easily electrostatically bonded with endotoxin in the blood, thereby achieving the purpose of adsorbing the endotoxin.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the technical field of adsorbent preparation, and in particular to an adsorbent for blood perfusion and a preparation method thereof. Background Art

[0002] Sepsis is a systemic inflammatory response syndrome caused by the invasion of pathogenic microorganisms such as bacteria into the body. It not only manifests as symptoms of systemic inflammatory response syndrome and primary infection lesions, but critically ill patients often also have symptoms of organ hypoperfusion. If not discovered and treated early, it may lead to shock, multiple organ failure, and even death. Symptoms of sepsis may include slurred speech or confusion, tremors or muscle pain / fever, anuria all day, severe dyspnea, a feeling of impending death, and mottled or discolored skin.

[0003] The pathogenesis of sepsis is complex, and the complex pathogenic factors also bring great difficulties to the treatment of sepsis. According to modern pathophysiological and proteomics analysis, endotoxin and various inflammatory factors are important causes of the occurrence and development of sepsis. Endotoxin is a lipopolysaccharide (LPS) component in the cell wall of Gram-negative bacteria. It is only released after the bacteria die and lyse. Endotoxin has many biological activities, including activation of leukocytes and complement system, stabilization of lysosomal membrane, and enhancement of phagocytosis. The toxicity of endotoxin is weak, and usually only causes obvious clinical symptoms at high concentrations; endotoxin is an important initiator of excessive systemic inflammatory response in sepsis. It stimulates monocytes or polymorphonuclear leukocytes to produce and release a series of cytokines by binding to the specific receptor CD14 on the membrane of monocytes or macrophages or polymorphonuclear leukocytes, thereby producing a systemic acute inflammatory response. These cytokines will further stimulate other cells to synthesize and release more cytokines, forming a network, which ultimately leads to excessive systemic inflammatory response and tissue and organ damage.

[0004] Inflammatory factors are a class of chemical substances released during infection and inflammatory response, and they play an important role in immune response. In the case of sepsis, inflammatory factors can come from infected lesions, damaged tissues, or the immune system. Common inflammatory factors include tumor necrosis factor (TNF), interleukin (IL), C-reactive protein (CRP), etc. These inflammatory factors often increase during the occurrence of sepsis caused by infection and can be used as important indicators for the diagnosis and monitoring of sepsis. Among them, TNF-α is a proinflammatory cytokine that can induce the synthesis and release of other inflammatory factors, thereby exacerbating the inflammatory response; IL-1, IL-6 and IL-8 are other important inflammatory factors that are involved in regulating immune responses and inducing acute phase reactions; CRP is an acute phase response protein synthesized by the liver, which can bind to bacterial cell wall components, activate the complement system, and induce inflammatory responses.

[0005] Therefore, developing an adsorbent material that can simultaneously remove endotoxins and inflammatory factors has important economic value and social significance. Summary of the invention

[0006] In view of the deficiencies of the prior art, the object of the present invention is to provide an adsorbent for blood perfusion and a preparation method thereof, wherein the prepared adsorbent has good adsorption performance for endotoxins and inflammatory factors in the blood.

[0007] In order to achieve the above object, the present invention adopts the following technical scheme:

[0008] A method for preparing an adsorbent for blood perfusion comprises the following steps:

[0009] S1, adding an emulsifier, sodium lauryl sulfate, and a co-emulsifier, polyvinyl alcohol, into deionized water, heating and stirring to dissolve, and obtaining an aqueous phase;

[0010] S2, adding styrene, divinylbenzene, olefinic acid, modified titanium dioxide and initiator benzoyl peroxide into toluene solvent, stirring and dispersing them uniformly to obtain an oil phase;

[0011] S3, under stirring conditions, dripping the oil phase into the water phase, heating for reaction, after the reaction is completed, filtering, washing, and extracting toluene to obtain a composite carrier;

[0012] S4. Dispersing the composite carrier in deionized water, then adding β-glucan and phosphoric acid thereto, heating and stirring to react, and after the reaction is completed, filtering, washing and drying to obtain an adsorbent.

[0013] Preferably, in step S1, the mass ratio of sodium dodecyl sulfate, polyvinyl alcohol and deionized water is 1-3:0.8-2:100.

[0014] Preferably, in step S2, the mass ratio of styrene, divinylbenzene, olefinic acid, modified titanium dioxide and benzoyl peroxide is 60-80:10-15:8-12:3-5:1-3.

[0015] Preferably, in step S2, the preparation method of the modified titanium dioxide is as follows: disperse nano titanium dioxide in an ethanol aqueous solution, then add a vinyl silane coupling agent thereto, stir for 2-4 hours, filter, wash and dry to obtain the modified titanium dioxide.

[0016] Preferably, the mass ratio of nano titanium dioxide to vinyl silane coupling agent is 5-10:1-3.

[0017] Preferably, in step S2, the carbon chain length of the olefinic acid is greater than or equal to C8.

[0018] Preferably, in step S3, the heating reaction temperature is 70-85° C., and the heating reaction time is 2-4 h.

[0019] Preferably, in step S4, the mass ratio of the composite carrier, β-glucan and phosphoric acid is 10-15:2-4:1-2.

[0020] Preferably, in step S4, the temperature of the heating and stirring reaction is 75-80° C., and the time of the heating and stirring reaction is 3-5 h.

[0021] The present invention also provides an adsorbent for blood perfusion prepared by the above preparation method.

[0022] Compared with the prior art, the present invention has the following beneficial effects:

[0023] (1) The present invention first modifies nano-titanium dioxide and introduces carbon-carbon double bonds on the surface of the nano-titanium dioxide. Then, through the double bond addition reaction, the olefinic acid and the nano-titanium dioxide are grafted onto the composite carrier. Through the nano effect (small size effect) of the nano-titanium dioxide and the interaction between the long hydrophobic alkyl chains in the olefinic acid, the adsorbent's adsorption capacity for inflammatory factors is greatly improved.

[0024] (2) The present invention grafts β-glucan onto the surface of the composite carrier by esterification reaction between the carboxyl group in the olefinic acid and the hydroxyl group in the β-glucan. The β-glucan is easily electrostatically bonded with the endotoxin in the blood, thereby achieving the purpose of adsorbing the endotoxin.

[0025] (3) The adsorbent prepared by the present invention has excellent adsorption capacity for endotoxins and inflammatory factors in the blood, and can be used to treat systemic inflammatory diseases such as sepsis. BRIEF DESCRIPTION OF THE DRAWINGS

[0026] Figure 1 This is a diagram showing the static adsorption effect of the adsorbent on various toxins in fresh plasma. DETAILED DESCRIPTION

[0027] The present invention is further described in detail below through specific preferred embodiments, but the present invention is not limited to the following embodiments.

[0028] It should be noted that, unless otherwise specified, the chemical reagents involved in the present invention were purchased through commercial channels.

[0029] A method for preparing an adsorbent for blood perfusion comprises the following steps:

[0030] S1. Preparation of aqueous phase

[0031] The emulsifier sodium lauryl sulfate and the auxiliary emulsifier polyvinyl alcohol are added into deionized water, heated and stirred to dissolve, and the aqueous phase is obtained.

[0032] In this step, the mass ratio of sodium dodecyl sulfate, polyvinyl alcohol and deionized water is 1-3:0.8-2:100. In some embodiments of the present invention, typically but not limiting, for example, it can be selected as 1:0.8:100, 2:1:100, 1:1:100, 2:2:100, 3:1:100, 3:2:100.

[0033] The heating and stirring temperature is 80-90°C, for example, it can be selected as 80°C, 81°C, 82°C, 83°C, 84°C, 85°C, 86°C, 87°C, 88°C, 89°C, 90°C; the heating and stirring time is 3-6h, for example, it can be selected as 3h, 4h, 5h, 6h.

[0034] S2. Preparation of oil phase

[0035] Add styrene, divinylbenzene, olefinic acid, modified titanium dioxide and initiator benzoyl peroxide into toluene solvent, stir and disperse them uniformly to obtain an oil phase.

[0036] In this step, the mass ratio of styrene, divinylbenzene, olefinic acid, modified titanium dioxide and benzoyl peroxide is 60-80:10-15:8-12:3-5:1-3, and further preferably 65-70:12-14:9-10:3-4:1-2.

[0037] In this step, the preparation method of modified titanium dioxide is as follows: disperse nano titanium dioxide in an ethanol aqueous solution, then add a vinyl silane coupling agent thereto, stir for 2-4 hours, filter, wash and dry to obtain modified titanium dioxide.

[0038] Wherein, the mass ratio of nano titanium dioxide and vinyl silane coupling agent is 5-10:1-3. In some embodiments of the present invention, it can be selected as 5:1, 5:2, 8:1, 8:2, 10:1, 10:2, 10:3.

[0039] In the present invention, the particle size of the nano titanium dioxide used is 40-60nm;

[0040] The selected vinyl silane coupling agent may be one or more of vinyl trimethoxy silane, vinyl triethoxy silane, and KH570;

[0041] The mass fraction of ethanol in the ethanol aqueous solution is 60-80%;

[0042] In the present invention, the carbon chain length of the enoic acid is greater than or equal to C8, for example, it can be selected from undecenoic acid, tetradecenoic acid, hexadecenoic acid, and octadecenoic acid.

[0043] S3. Preparation of composite carrier

[0044] Under stirring conditions, the oil phase is dropped into the water phase, heated for reaction, and after the reaction is completed, the composite carrier is obtained by filtering, washing, and extracting toluene.

[0045] In this step, the stirring speed is 400-800 r / min, for example, it can be selected as 400 r / min, 500 r / min, 600 r / min, 700 r / min, 800 r / min.

[0046] The temperature of the heating reaction is 70-85°C, for example, 70°C, 75°C, 80°C, 85°C; the time of the heating reaction is 2-4h, for example, 2h, 3h, 4h.

[0047] S4. Preparation of adsorbent

[0048] The composite carrier is dispersed in deionized water, and then β-glucan and phosphoric acid are added thereto, heated and stirred for reaction, and after the reaction is completed, filtered, washed and dried to obtain an adsorbent.

[0049] In this step, the mass ratio of the composite carrier, β-glucan and phosphoric acid is 10-15:2-4:1-2. In some embodiments of the present invention, for example, it can be selected as 10:2:1, 10:2:2, 10:3:1, 10:3:2, 12:3:1, 12:4:2, 15:2:1, 15:3:1, 15:4:1, 15:4:2.

[0050] In this step, the temperature of the heating and stirring reaction is 75-80°C, for example, 75°C, 76°C, 77°C, 78°C, 79°C, 80°C; the time of the heating and stirring reaction is 3-5h, for example, 3h, 4h, 5h.

[0051] The present invention will be further described below by means of specific examples.

[0052] Example 1

[0053] A method for preparing an adsorbent for blood perfusion comprises the following steps:

[0054] S1, add 10g of emulsifier sodium lauryl sulfate and 5g of co-emulsifier polyvinyl alcohol into 500g of deionized water, heat and stir at 85°C to dissolve, and obtain an aqueous phase;

[0055] S2, add 65g styrene, 15g divinylbenzene, 10g undecylenic acid, 4g modified titanium dioxide and 2g initiator benzoyl peroxide into 150mL toluene solvent, stir and disperse evenly to obtain an oil phase;

[0056] The preparation method of modified titanium dioxide is as follows: 6 g of nano titanium dioxide is dispersed in 100 g of 60 wt% ethanol aqueous solution, and then 1 g of vinyltrimethoxysilane is added thereto, stirred for 3 h, filtered, washed, and dried to obtain modified titanium dioxide;

[0057] S3, under the stirring condition of 600r / min, drop the oil phase into the water phase, heat and react at 80°C for 2h, after the reaction is completed, filter, wash and extract toluene to obtain a composite carrier;

[0058] S4. Disperse 10 g of the composite carrier in 150 g of deionized water, then add 2 g of β-glucan and 1 g of phosphoric acid, heat and stir at 80° C. to react for 3 h. After the reaction is completed, filter, wash and dry to obtain an adsorbent.

[0059] Example 2

[0060] A method for preparing an adsorbent for blood perfusion comprises the following steps:

[0061] S1, add 12g of emulsifier sodium lauryl sulfate and 4g of co-emulsifier polyvinyl alcohol into 500g of deionized water, heat and stir at 85°C to dissolve, and obtain an aqueous phase;

[0062] S2, add 60g styrene, 10g divinylbenzene, 12g hexadecene acid, 4g modified titanium dioxide and 1g initiator benzoyl peroxide into 150mL toluene solvent, stir and disperse evenly to obtain an oil phase;

[0063] The preparation method of modified titanium dioxide is as follows: 5g of nano titanium dioxide is dispersed in 100g of 60wt% ethanol aqueous solution, and then 1g of vinyltrimethoxysilane is added thereto, stirred for 3h, filtered, washed and dried to obtain modified titanium dioxide;

[0064] S3, under the stirring condition of 600r / min, drop the oil phase into the water phase, heat and react at 85°C for 2h, after the reaction is completed, filter, wash and extract toluene to obtain a composite carrier;

[0065] S4. Disperse 12 g of the composite carrier in 150 g of deionized water, then add 3 g of β-glucan and 1 g of phosphoric acid, heat and stir at 80° C. to react for 3 h. After the reaction is completed, filter, wash and dry to obtain an adsorbent.

[0066] Example 3

[0067] A method for preparing an adsorbent for blood perfusion comprises the following steps:

[0068] S1, add 15g of emulsifier sodium lauryl sulfate and 6g of co-emulsifier polyvinyl alcohol into 500g of deionized water, heat and stir at 85°C to dissolve, and obtain an aqueous phase;

[0069] S2, add 70g styrene, 15g divinylbenzene, 8g tetradecenoic acid, 3g modified titanium dioxide and 1g initiator benzoyl peroxide into 150mL toluene solvent, stir and disperse evenly to obtain an oil phase;

[0070] The preparation method of modified titanium dioxide is as follows: 10g of nano titanium dioxide is dispersed in 100g of 60wt% ethanol aqueous solution, and then 3g of vinyltrimethoxysilane is added thereto, stirred for 3h, filtered, washed and dried to obtain modified titanium dioxide;

[0071] S3, under the stirring condition of 600r / min, drop the oil phase into the water phase, heat and react at 70°C for 4h, after the reaction is completed, filter, wash and extract toluene to obtain a composite carrier;

[0072] S4. Disperse 15 g of the composite carrier in 150 g of deionized water, then add 4 g of β-glucan and 2 g of phosphoric acid, heat and stir at 75°C for 5 h, and after the reaction is completed, filter, wash and dry to obtain the adsorbent.

[0073] Example 4

[0074] A method for preparing an adsorbent for blood perfusion comprises the following steps:

[0075] S1, add 8g of emulsifier sodium lauryl sulfate and 10g of co-emulsifier polyvinyl alcohol into 500g of deionized water, heat and stir at 85°C to dissolve, and obtain an aqueous phase;

[0076] S2, add 80g styrene, 10g divinylbenzene, 10g octadecenoic acid, 5g modified titanium dioxide and 3g initiator benzoyl peroxide into 150mL toluene solvent, stir and disperse evenly to obtain an oil phase;

[0077] The preparation method of modified titanium dioxide is as follows: 10g of nano titanium dioxide is dispersed in 100g of 60wt% ethanol aqueous solution, and then 2g of vinyltrimethoxysilane is added thereto, stirred for 3h, filtered, washed and dried to obtain modified titanium dioxide;

[0078] S3, under the stirring condition of 600r / min, drop the oil phase into the water phase, heat and react at 85°C for 2h, after the reaction is completed, filter, wash and extract toluene to obtain a composite carrier;

[0079] S4. Disperse 12 g of the composite carrier in 150 g of deionized water, then add 2 g of β-glucan and 1.5 g of phosphoric acid, heat and stir at 75°C for 5 h, and after the reaction is completed, filter, wash and dry to obtain the adsorbent.

[0080] Example 5

[0081] A method for preparing an adsorbent for blood perfusion comprises the following steps:

[0082] S1, add 10g of emulsifier sodium lauryl sulfate and 8g of auxiliary emulsifier polyvinyl alcohol into 500g of deionized water, heat and stir at 85°C to dissolve, and obtain an aqueous phase;

[0083] S2, add 80g styrene, 15g divinylbenzene, 12g undecylenic acid, 5g modified titanium dioxide and 3g initiator benzoyl peroxide into 150mL toluene solvent, stir and disperse evenly to obtain an oil phase;

[0084] The preparation method of modified titanium dioxide is as follows: 8g of nano titanium dioxide is dispersed in 100g of 60wt% ethanol aqueous solution, and then 2g of vinyltrimethoxysilane is added thereto, stirred for 3h, filtered, washed and dried to obtain modified titanium dioxide;

[0085] S3, under the stirring condition of 600r / min, drop the oil phase into the water phase, heat and react at 85°C for 2h, after the reaction is completed, filter, wash and extract toluene to obtain a composite carrier;

[0086] S4. Disperse 12 g of the composite carrier in 150 g of deionized water, then add 3 g of β-glucan and 1 g of phosphoric acid, heat and stir at 75°C for 5 h, and after the reaction is completed, filter, wash and dry to obtain the adsorbent.

[0087] Comparative Example 1

[0088] A method for preparing an adsorbent for blood perfusion comprises the following steps:

[0089] S1, add 10g of emulsifier sodium lauryl sulfate and 5g of co-emulsifier polyvinyl alcohol into 500g of deionized water, heat and stir at 85°C to dissolve, and obtain an aqueous phase;

[0090] S2, add 65g styrene, 15g divinylbenzene, 10g undecylenic acid, 4g modified titanium dioxide and 2g initiator benzoyl peroxide into 150mL toluene solvent, stir and disperse evenly to obtain an oil phase;

[0091] The preparation method of modified titanium dioxide is as follows: 6 g of nano titanium dioxide is dispersed in 100 g of 60 wt% ethanol aqueous solution, and then 1 g of vinyltrimethoxysilane is added thereto, stirred for 3 h, filtered, washed, and dried to obtain modified titanium dioxide;

[0092] S3. Under stirring conditions of 600 r / min, drop the oil phase into the water phase, heat and react at 80°C for 2 hours. After the reaction is completed, filter, wash and extract toluene to obtain the adsorbent.

[0093] Comparative Example 2

[0094] A method for preparing an adsorbent for blood perfusion comprises the following steps:

[0095] S1, add 10g of emulsifier sodium lauryl sulfate and 5g of co-emulsifier polyvinyl alcohol into 500g of deionized water, heat and stir at 85°C to dissolve, and obtain an aqueous phase;

[0096] S2, add 65g styrene, 15g divinylbenzene, 10g undecylenic acid and 2g initiator benzoyl peroxide into 150mL toluene solvent, stir and disperse evenly to obtain an oil phase;

[0097] S3, under the stirring condition of 600r / min, drop the oil phase into the water phase, heat and react at 80°C for 2h, after the reaction is completed, filter, wash and extract toluene to obtain a composite carrier;

[0098] S4. Disperse 10 g of the composite carrier in 150 g of deionized water, then add 2 g of β-glucan and 1 g of phosphoric acid, heat and stir at 80° C. to react for 3 h. After the reaction is completed, filter, wash and dry to obtain an adsorbent.

[0099] Comparative Example 3

[0100] A method for preparing an adsorbent for blood perfusion comprises the following steps:

[0101] S1, add 10g of emulsifier sodium lauryl sulfate and 5g of co-emulsifier polyvinyl alcohol into 500g of deionized water, heat and stir at 85°C to dissolve, and obtain an aqueous phase;

[0102] S2, add 65g styrene, 15g divinylbenzene, 4g modified titanium dioxide and 2g initiator benzoyl peroxide into 150mL toluene solvent, stir and disperse evenly to obtain an oil phase;

[0103] The preparation method of modified titanium dioxide is as follows: 6 g of nano titanium dioxide is dispersed in 100 g of 60 wt% ethanol aqueous solution, and then 1 g of vinyltrimethoxysilane is added thereto, stirred for 3 h, filtered, washed, and dried to obtain modified titanium dioxide;

[0104] S3. Under stirring conditions of 600 r / min, drop the oil phase into the water phase, heat and react at 80°C for 2 hours. After the reaction is completed, filter, wash and extract toluene to obtain the adsorbent.

[0105] The performance test of the adsorbent prepared in Example 1 and Comparative Examples 1-3 was carried out, and the specific steps were as follows:

[0106] Endotoxin, TNF-α, IL-6, and heparin binding protein (HBP) were added to fresh plasma to make the endotoxin content in the plasma 5EU / mL, the concentrations of TNF-α and IL-6 500ng / mL, and the concentration of HBP 300ng / mL, and set aside.

[0107] Take 0.5 mL of the adsorbent resin prepared in Example 1 and Comparative Examples 1-3 respectively in a centrifuge tube, add 5 mL of the above plasma solution, seal, shake and adsorb in a shaker at 37°C for 2 h, centrifuge after adsorption, take the upper liquid to determine the concentration of each substance, and calculate the adsorption rate of each substance by the concentration difference before and after adsorption. The above experiment was repeated five times and the average value was taken. The results are as follows Figure 1 As shown in the figure, it can be seen that the adsorbent prepared by the present invention has a high adsorption rate for various toxins in plasma.

[0108] Finally, it should be noted that the above embodiments do not limit the present invention in any form. For those skilled in the art, some modifications and improvements can be made to the present invention. Therefore, any modification or improvement made without departing from the spirit of the present invention belongs to the scope of protection claimed in the present invention.

Claims

1. A method for preparing an adsorbent for blood perfusion, characterized in that: The steps include: S1, adding an emulsifier, sodium lauryl sulfate, and a co-emulsifier, polyvinyl alcohol, into deionized water, heating and stirring to dissolve, and obtaining an aqueous phase; S2, adding styrene, divinylbenzene, olefinic acid, modified titanium dioxide and initiator benzoyl peroxide into toluene solvent, stirring and dispersing them uniformly to obtain an oil phase; S3, under stirring conditions, dripping the oil phase into the water phase, heating for reaction, after the reaction is completed, filtering, washing, and extracting toluene to obtain a composite carrier; S4, dispersing the composite carrier in deionized water, then adding β-glucan and phosphoric acid thereto, heating and stirring to react, and after the reaction is completed, filtering, washing and drying to obtain an adsorbent; Wherein, in step S2, the preparation method of the modified titanium dioxide is as follows: disperse nano titanium dioxide in an ethanol aqueous solution, then add a vinyl silane coupling agent thereto, stir for 2-4 hours, filter, wash, and dry to obtain the modified titanium dioxide; In step S2, the carbon chain length of the olefinic acid is greater than or equal to C8.

2. The method for preparing an adsorbent for blood perfusion according to claim 1, characterized in that: In step S1, the mass ratio of sodium dodecyl sulfate, polyvinyl alcohol and deionized water is 1-3:0.8-2:

100.

3. The method for preparing an adsorbent for blood perfusion according to claim 1, characterized in that: In step S2, the mass ratio of styrene, divinylbenzene, olefinic acid, modified titanium dioxide and benzoyl peroxide is 60-80:10-15:8-12:3-5:1-3.

4. The method for preparing an adsorbent for blood perfusion according to claim 1, characterized in that: The mass ratio of nano titanium dioxide to vinyl silane coupling agent is 5-10:1-3.

5. The method for preparing an adsorbent for blood perfusion according to claim 1, characterized in that: In step S3, the heating reaction temperature is 70-85° C., and the heating reaction time is 2-4 h.

6. The method for preparing an adsorbent for blood perfusion according to claim 1, characterized in that: In step S4, the mass ratio of the composite carrier, β-glucan and phosphoric acid is 10-15:2-4:1-2.

7. The method for preparing an adsorbent for blood perfusion according to claim 1, characterized in that: In step S4, the temperature of the heating and stirring reaction is 75-80° C., and the time of the heating and stirring reaction is 3-5 h.

8. An adsorbent for blood perfusion prepared by the preparation method according to any one of claims 1 to 7.